SCHEMBL9537313

SCHEMBL9537313

Cc1cccc2c(=O)n3ccsc3nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.52
CYP1A2 P05177 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PKM P14618 6/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 3/20 0.44
HSD17B10 Q99714 2/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
PARP1 P09874 1/20 0.42
ELANE P08246 1/20 0.42
LMNA P02545 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
PDE7A Q13946 1/20 0.41
PDE7B Q9NP56 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9536991 0.82 CYP1A2 (0.50) GAACYP1A2TDP1PKMSMN1; SMN2
SCHEMBL9535677 0.82 TDP1 (0.50) GAACYP1A2TDP1PKMSMN1; SMN2
SCHEMBL9770496 0.82 CYP1A2 (0.43) GAACYP1A2TDP1PKMSMN1; SMN2
SCHEMBL10696259 0.82 CYP1A2 (0.43) GAACYP1A2TDP1PKMSMN1; SMN2
SCHEMBL9534241 0.82 PKM (0.50) CYP1A2TDP1PKMSMN1; SMN2MAPT
SCHEMBL28345207 0.80 CHEK1 (0.51) GAACYP1A2TDP1SMN1; SMN2MAPT
SCHEMBL9770674 0.79 CYP1A2 (0.50) GAACYP1A2TDP1PKMSMN1; SMN2
SCHEMBL9534426 0.79 ALDH1A1 (0.43) CYP1A2TDP1PKMMAPTHSD17B10
SCHEMBL9535141 0.77 CYP1A2 (0.50) GAACYP1A2TDP1PKMSMN1; SMN2
SCHEMBL10695623 0.77 KDM4E (0.51) SMN1; SMN2MAPTHPGDPARP1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0263523-B1 Process for the preparation of thiazolo [2,3-b] quinazolones BASF AG (DE) 1993-12-29 EP disclosed
EP-0263523-A2 Process for the preparation of thiazolo [2,3-b] quinazolones BASF Aktiengesellschaft (DE) 1988-04-13 EP disclosed